Georgia General Assembly Establishes Life Sciences Caucus to Advance Innovation and Industry Growth

Georgia Life Sciences leads effort to establish bipartisan caucus focused on advancing the state’s growing life sciences economy

March 17, 2026, Atlanta, GA – The Georgia General Assembly has announced the formation of the Life Sciences Caucus through HR 1474, a bipartisan, bicamural, initiative designed to strengthen understanding of Georgia’s rapidly growing life sciences sector and support policies that drive innovation, company growth, and economic opportunity across the state.



Developed and championed by Georgia Life Sciences (GLS), the caucus will serve as a platform for legislators to engage with industry leaders, researchers, and educators to better understand the opportunities and challenges shaping biotechnology, medical technology, pharmaceuticals, and advanced biomanufacturing in Georgia.


“The life sciences industry plays a vital role in Georgia’s economy, advancing groundbreaking research, creating high-quality jobs, and improving health outcomes,” said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. “The Life Sciences Caucus will provide an important forum for collaboration and dialogue as policymakers work to support an environment where innovation and companies can thrive.”


Georgia’s life sciences sector continues to expand, with companies and institutions across the state driving new discoveries, scaling manufacturing capabilities, and attracting investment. The caucus will help ensure lawmakers have access to insights and perspectives from across the ecosystem as they consider policies that impact the industry’s continued growth.


Georgia Life Sciences extends its sincere thanks to the legislators who sponsored and supported the formation of the caucus, including Senators Drew Echols, Frank Ginn, Chuck Hufstetler, Michael ‘Doc” Rhett, Shawn Still, Carden Summers, Ben Watson, and Kenya Wicks, as well as House members Matt Dubnik, John LaHood, Karen Mathiak, Ron Stephens, Brad Thomas, and Bill Yearta.


Through the Life Sciences Caucus, legislators will have opportunities to learn more about the state’s innovation ecosystem, workforce needs, and policy priorities that can help Georgia remain competitive as a national hub for life sciences research, development, and manufacturing.


About Georgia Life Sciences


Georgia Life Sciences (GLS) is the state’s leading industry organization representing biotechnology, pharmaceutical, medical device, and digital health companies, along with research institutions and other ecosystem partners. GLS works to advance Georgia’s life sciences sector by supporting innovation, advocating for policies that enable growth, and developing the workforce needed to power the industry’s future.

October 28, 2026
New national report highlights Georgia’s growing bioscience workforce, research enterprise, and investment activity October 28— Georgia’s bioscience industry continues to expand its economic footprint, supporting 42,605 jobs across 4,281 business establishments statewide in 2025, according to a new report examining the economic impact of the U.S. bioscience industry. The U.S. Bioscience Economy: Advancing Innovation and Strengthening States and Regions, published by the Biotechnology Innovation Organization (BIO), the Council of State Bioscience Associations, and TEConomy Partners, provides a comprehensive assessment of the bioscience industry’s contributions to employment, wages, business growth, university research and development, and access to capital across all 50 states, Washington, D.C., and Puerto Rico. Georgia’s bioscience employment grew 7.6% between 2021 and 2025, slightly outpacing national growth. The state recorded employment gains across all five major bioscience industry subsectors, demonstrating the breadth of its life sciences economy. “Georgia’s bioscience industry is an important contributor to our state’s economic competitiveness, creating high-quality jobs and advancing research and innovation,” said Maria Thacker Goethe, President and CEO of Georgia Life Sciences. “These findings underscore the opportunity to build on Georgia’s strengths by strengthening connections among research institutions, industry, investors, and workforce partners to help more life sciences companies innovate and grow here.” Georgia’s Bioscience Industry: Key Findings The report highlights several indicators of Georgia’s bioscience industry strength: 42,605 jobs: Georgia’s bioscience industry employed more than 42,000 people in 2025, with employment growing 7.6% from 2021 to 2025. 4,281 business establishments: Bioscience companies and related businesses operate across the state, contributing to Georgia’s diverse economic base. $112,712 in average annual wages: Bioscience industry wages exceeded Georgia’s private-sector average by 52%, highlighting the sector’s contribution to high-value employment. $2.0 billion in university bioscience research: Georgia universities conducted $2.0 billion in bioscience-related research and development in fiscal year 2024. $789.5 million in NIH funding: Georgia institutions received $789.5 million in National Institutes of Health funding in fiscal year 2025. $1.5 billion in venture capital investment: Georgia bioscience companies attracted $1.5 billion in venture capital from 2021 through 2025. Georgia’s bioscience distribution subsector, the state’s largest, expanded employment by 10.3% during the period. Agricultural feedstock and industrial biosciences recorded the fastest percentage growth, reflecting the breadth of activity across the state’s bioscience economy. National Industry Impact Nationally, the U.S. bioscience industry generated $3.19 trillion in total economic output and directly employed 2.31 million Americans across more than 156,000 business establishments. The report examines the industry's economic footprint and the factors that support its continued growth, including research investment, workforce development, and access to capital. Building on Georgia’s Life Sciences Momentum The findings highlight Georgia’s substantial research enterprise, established industry base, and ability to attract investment. Continued growth will depend on strengthening the connections that help translate scientific discoveries into commercial opportunities, expand access to capital, develop a skilled workforce, and provide the infrastructure companies need to scale. Georgia Life Sciences works to advance the state’s life sciences ecosystem through policy and advocacy, workforce development, industry convening, and strategic collaboration. Its statewide roadmap, Pathways & Partnerships: A Roadmap for Georgia’s Life Sciences Sector, outlines a long-term vision for positioning Georgia as a leading scale-up manufacturing hub in the Southeast. “Georgia has significant assets across research, manufacturing, workforce, and logistics,” Goethe said. “By coordinating these strengths and addressing the gaps that can limit company growth, we can create more opportunities for innovation, investment, and long-term economic impact across the state.” Read the Report The full report, The U.S. Bioscience Economy: Advancing Innovation and Strengthening States and Regions, and Georgia’s state-specific profile are available from the Biotechnology Innovation Organization. Explore the national report and findings Download Georgia’s state profile (PDF)
October 22, 2026
Georgia Life Sciences connected 23 educators with hands-on STEM learning and industry experts at its Savannah workshop to strengthen the workforce pipeline.
October 22, 2026
Georgia Life Sciences Institute connects 23 chemistry teachers with industry professionals to bring real-world career opportunities into the classroom. The Georgia Life Sciences Institute (GLSI) recently organized an industry visit for 23 Forsyth County chemistry teachers to Bend Bioscience in Gainesville, Georgia, offering educators a firsthand look at the careers, skills, and opportunities available within the state's growing life sciences sector. During the visit, teachers engaged directly with Bend Bioscience employees, toured the facility, and explored how concepts taught in chemistry classrooms translate into real-world applications. Conversations focused on workforce needs, career pathways, and the combination of technical and professional skills that help employees succeed in the life sciences industry. A particular area of interest was Quality Assurance and Quality Control (QA/QC), functions essential to maintaining the quality, safety, and consistency of life sciences products. These discussions helped educators better understand the range of careers available to students, including opportunities beyond traditional research and laboratory roles. The experience also demonstrated the impact of connecting educators directly with industry. Several participating teachers shared that the visit inspired them to discuss life sciences career opportunities with their own children, illustrating how greater career awareness can extend beyond the classroom. Both the educators and Bend Bioscience team expressed interest in continued engagement, reinforcing the value of building stronger connections between Georgia's schools and life sciences employers. Connecting Education and Industry Through initiatives like this visit, GLSI works to bridge the gap between education and industry by giving teachers direct exposure to the companies, technologies, and careers shaping Georgia's life sciences ecosystem. By equipping educators with firsthand industry knowledge, GLSI helps bring greater career awareness and real-world relevance into classrooms across the state, introducing students to pathways they may not have previously considered. Georgia Life Sciences Institute extends its appreciation to Bend Bioscience for welcoming Forsyth County educators and investing time in the teachers who help prepare Georgia's future workforce. Together, these partnerships are helping build awareness of the diverse opportunities available in Georgia's life sciences industry and strengthen the state's future talent pipeline.
MORE POSTS